Relavo, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Relavo, Inc. - overview
Established
2019
Location
Brooklyn, NY, US
Primary Industry
Medical Devices & Equipment
About
Based in New York, US, and founded in 2019, Relavo Inc operates as a medical device company that primarily serves kidney failure patients by offering PeritoneX, a medical technology for home dialysis. The company was founded by Sarah Lee (CEO), Tejasvi Desai (CTO), and Anna Bailey. In February 2023, National Kidney Foundation invested in Relavo, Inc. It offers medical devices as a solution that help patients to receive dialysis treatment in their homes.
The firm provides peritoneX which is an inline connection device that disinfects dialysis tubes at all connections in the PD system. The device is accessible with existing PD systems and reduces the risk of secondary contamination.
Current Investors
National Kidney Foundation
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.relavomedical.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Relavo, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Direct | Completed | Relavo, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.